Result Page 2 for GSK news & latest pictures from ibtimes.co.uk

RBS Confirms Chairman Sir Philip Hampton is Leaving for GlaxoSmithKline

Hampton will join GSK in January 2015 as a non-executive director before assuming chairman's role.

GSK's China Consumer Healthcare Unit was Probed by US Authorities

GSK in 2012 conducted focused investigation into specific people and suppliers in China in connection with US probe.

GSK's Experimental Ebola Vaccine Approved for Testing on Humans

GSK is developing the vaccine with the Vaccine Research Centre of America's National Institutes of Health.

GlaxoSmithKline Faces Fresh Bribery Allegations in Syria

Company allegedly paid bribes to doctors and officials in cash and kind.

More news

GlaxoSmithKline 'Private Eyes' Peter Humphrey and Yingzeng Yu Charged in China

British investigator Peter Humphrey and his wife Yingzeng Yu were indicted for allegedly obtaining and selling information illegally.

US Vex Concerns Over Being Barred from Peter Humphrey and Yu Yingzeng Trial Over GSK-related Work

Humphrey and his wife were arrested in 2013 following work they did for GlaxoSmithKline

Ex-GlaxoSmithKline Boss Mark Reilly's Sex Tape Sparked China Bribery Probe

GSK confirmed the existence of the tape on 29 June but did not disclose details.

Irish Baby Graves Scandal: 2,000 Children Used as Drug 'Guinea-Pigs'

Orphans at homes where graves uncovered were used to test diphtheria vaccine.

GlaxoSmithKline Makes $105m Settlement With US States Over Illegal Marketing

GSK was accused of mis-promoting asthma medication Advair and anti-depressants Paxil and Wellbutrin.

GSK Under Criminal Investigation by UK Serious Fraud Office

UK's largest pharmaceuticals firm, GlaxoSmithKline, subject to probe of "commercial practices".

Drugmakers Suffer 5% Cut in China Profit Margins Amid Crackdown

Drugmakers' profits and margins decline in China due to crackdown on corruption and price cuts.

GSK China Marketing Team Formed To Bribe Hospitals

China's Crackdown on GlaxoSmithKline Bribery Scandal is A Warning to Foreign Firms, says Xinhua

Briton Mark Reilly and China's Zhang Guowei and Zhao Hongyan were charged with corruption in May

GlaxoSmithKline Seeks China Bribery Scandal Resolution as Mark Reilly and Execs Charged With Corruption

China charged former boss of GSK's China unit, Mark Reilly, and two other executives with corruption

China is cracking down on the pharmaceutical sector after it claimed GSK executives bribed doctors (Photo: Reuters)

GlaxoSmithKline's Former China Boss Mark Reilly and Two Others Charged With Corruption

Two Chinese executives, Zhang Guowei and Zhao Hongyan, are also suspected of bribing officials.

China Unveiling GlaxoSmithKline Bribery Investigation Details

China accuses GSK executives of routing 3bn yuan in bribes to doctors through travel agencies and consultancies

GlaxoSmithKline Neglects to Unveil China Bribery Scandal Financial Impact

GSK shares fell after Britain's biggest drug maker also showed 10% drop in first quarter sales

GlaxoSmithKline Faces Criminal Bribery Probe in Poland

GSK executives in China are already under investigation for routing 3bn yuan in bribes through agencies

GlaxoSmithKline Sacks Staff on China Bribery Scandal

Doctors are accused of routing 3bn yuan in bribes to doctors through travel agencies and consultancies

European Markets Rise on Strong Eurozone PMI Data

Investors await GlaxoSmithKline Q4 earnings update due at 12.00 GMT.

European markets trade higher on 16 December

European Markets Rise Amid Federal Reserve QE Taper Uncertainty

The US Fed's FOMC will meet on 17-18 December.

Asian markets trade lower on 16 December

Asian Markets Down on China Data and Federal Reserve QE Taper Jitters

US Federal Reserve's FOMC will meet on 17-18 December.

GlaxoSmithKline to Increase Stake in Indian Unit With $1bn Open Offer

Move indicates that GSK is more reliant on high-growth emerging markets than traditional western markets.

GlaxoSmithKline Pledges $330m to Upgraded Three UK Production Sites

GlaxoSmithKline Pledges £200m To Upgrade UK Production Sites

Britain's "Patent Box" tax breaks motivate GSK to invest more in UK.

GlaxoSmithKline Eyes £25m Scottish Expansion and Jobs Boost

The pharmaceutical giant GSK's move will create 25 new jobs in Montrose.

Reports say that GlaxoSmithKline (GSK) and Briton Mark Reilly, GSK's former head of China operations, will escape charges (Photo: Reuters)

GlaxoSmithKline to Escape China Bribery Charges as Individual Executives Blamed

Reports say the company and Briton Mark Reilly, GSK's former head of China operations, will escape charges

China, Malaysia, Indonesia and Vietnam World's Worst for Bribery and Corruption

Ernst & Young report reveals Asia has the worst defences against corporate fraud of any region.

MOST READ

GSK